Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DFT-383 by Novartis for Cystinosis: Likelihood of Approval
DFT-383 is under clinical development by Novartis and currently in Phase I for Cystinosis. According to GlobalData, Phase I drugs...